Eisai EMEA
Nicholas Sydenham has worked at Eisai EMEA since 2008. Nicholas started as a Medical Science Liaison and later became a Front-line Sales Manager for Epilepsy. In 2017, they were promoted to Commercial Effectiveness Director in the Neurology Business Group, overseeing the EMEA, Russia, and Oceania regions.
Nicholas Sydenham holds a Master's Degree in Management and Business Administration from IAE Clermont Auvergne - School of Management. Nicholas also obtained a Bachelor's degree in Political Science from Loughborough University.
This person is not in any offices
Eisai EMEA
3 followers
At Eisai, everything we do is dedicated to giving our first thought to patients and their families through our human health care (hhc) philosophy. We are the European hub of Tokyo-based Eisai Co. Ltd., forming part of a multinational team working across a global network of R&D facilities, manufacturing sites and marketing subsidiaries. Our collective passion and dedication to patient care is the driving force behind our efforts to discover and develop innovative medicines in a variety of therapeutic areas in which a high unmet medical need remains, including oncology and neurology. Our mission is clear; we strive to make a significant long-lasting contribution to society in an ethical, compliant and sustainable way by embodying our hhc philosophy in everything we do. For more information about Eisai in the EMEA region please visit www.eisai.eu Our community guidelines can be found here: https://www.eisai.eu/wp-content/uploads/Community-guidelines-v1.0.pdf For more information about how Eisai processes your data, please refer to our privacy policy here: https://www.eisai.eu/privacy-policy/ --- November 2023 | EMEA-NON-23-00180